Bio Green Med Solution Statistics
Total Valuation
BGMS has a market cap or net worth of $4.88 million. The enterprise value is $1.62 million.
| Market Cap | 4.88M |
| Enterprise Value | 1.62M |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BGMS has 5.52 million shares outstanding. The number of shares has increased by 2,980.44% in one year.
| Current Share Class | 5.52M |
| Shares Outstanding | 5.52M |
| Shares Change (YoY) | +2,980.44% |
| Shares Change (QoQ) | +18.49% |
| Owned by Insiders (%) | 32.24% |
| Owned by Institutions (%) | 2.15% |
| Float | 3.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.25 |
| Forward PS | n/a |
| PB Ratio | 0.73 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.06
| Current Ratio | 7.06 |
| Quick Ratio | 5.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 20.59% and return on invested capital (ROIC) is -126.93%.
| Return on Equity (ROE) | 20.59% |
| Return on Assets (ROA) | -49.33% |
| Return on Invested Capital (ROIC) | -126.93% |
| Return on Capital Employed (ROCE) | -65.88% |
| Weighted Average Cost of Capital (WACC) | 2.22% |
| Revenue Per Employee | $127,083 |
| Profits Per Employee | -$1.19M |
| Employee Count | 12 |
| Asset Turnover | 0.27 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BGMS has paid $37,000 in taxes.
| Income Tax | 37,000 |
| Effective Tax Rate | 3.53% |
Stock Price Statistics
The stock price has decreased by -75.03% in the last 52 weeks. The beta is -0.37, so BGMS's price volatility has been lower than the market average.
| Beta (5Y) | -0.37 |
| 52-Week Price Change | -75.03% |
| 50-Day Moving Average | 0.94 |
| 200-Day Moving Average | 1.60 |
| Relative Strength Index (RSI) | 49.89 |
| Average Volume (20 Days) | 586,219 |
Short Selling Information
The latest short interest is 193,285, so 3.50% of the outstanding shares have been sold short.
| Short Interest | 193,285 |
| Short Previous Month | 31,498 |
| Short % of Shares Out | 3.50% |
| Short % of Float | 5.59% |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, BGMS had revenue of $1.53 million and -$14.23 million in losses. Loss per share was -$4.11.
| Revenue | 1.53M |
| Gross Profit | -530,000 |
| Operating Income | -4.46M |
| Pretax Income | 1.05M |
| Net Income | -14.23M |
| EBITDA | -4.45M |
| EBIT | -4.46M |
| Loss Per Share | -$4.11 |
Balance Sheet
The company has $3.34 million in cash and n/a in debt, with a net cash position of $3.34 million or $0.60 per share.
| Cash & Cash Equivalents | 3.34M |
| Total Debt | n/a |
| Net Cash | 3.34M |
| Net Cash Per Share | $0.60 |
| Equity (Book Value) | 6.76M |
| Book Value Per Share | 1.22 |
| Working Capital | 4.83M |
Cash Flow
In the last 12 months, operating cash flow was -$1.80 million and capital expenditures -$1,000, giving a free cash flow of -$1.80 million.
| Operating Cash Flow | -1.80M |
| Capital Expenditures | -1,000 |
| Depreciation & Amortization | 4,500 |
| Net Borrowing | n/a |
| Free Cash Flow | -1.80M |
| FCF Per Share | -$0.33 |
Margins
Gross margin is -34.75%, with operating and profit margins of -292.39% and -204.20%.
| Gross Margin | -34.75% |
| Operating Margin | -292.39% |
| Pretax Margin | 68.72% |
| Profit Margin | -204.20% |
| EBITDA Margin | -292.10% |
| EBIT Margin | -292.39% |
| FCF Margin | n/a |
Dividends & Yields
BGMS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2,980.44% |
| Shareholder Yield | -2,980.44% |
| Earnings Yield | -287.12% |
| FCF Yield | -36.36% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 440.69% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 7, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jul 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
BGMS has an Altman Z-Score of -71.19 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -71.19 |
| Piotroski F-Score | 4 |